Now start-ups, universities and pharmaceutical companies are clambering to commercialize the potential of young blood. Venture capitalists and high-level hospital executives are rumored to be partaking behind the scenes. The idea's popularity is sparking fears of red markets and a dystopian future in which the old steal youth from the young, and no longer just metaphorically. Here, Adee discusses a safer, more effective way for blood to stop the inevitable declines of ageing.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados